Jim Cramer Slams Political Blocking Of 'LSD-Derived Antidepressants,' Citing Strong Test Data 'Showing They Worked' - ATAI Life Sciences (NASDAQ:ATAI), Compass Pathways (NASDAQ:CMPS)
Source: benzinga.com
Page 2 - Reading About Startups News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Reading About Startups. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Reading About Startups Today - Breaking & Trending Today
Jim Cramer Slams Political Blocking Of 'LSD-Derived Antidepressants,' Citing Strong Test Data 'Showing They Worked'
Jim Cramer recently hyped up one of his guests in advance of his CNBC show "Mad Money," posting on X that people "will be very interested in MindMed for certain ... LSD," and he made sure his interview did not disappoint. Mind Medicine Inc. (NASDAQ:MNMD) sees a massive market opportunity ahead, citing 21% of U.S. adults with an anxiety disorder, an estimated 4.4% of U.S. adults with attention-deficit/hyperactivity disorder (ADHD) and a $461 billion economic cost from autism spectrum disorder by
Source: yahoo.com